First-line zanidatamab plus chemotherapy leads to ‘practice-changing’ PFS and overall survival gains in a phase 3 study of ...

The new Apex Legends update is officially live, and it brings a mix of exciting changes that impact progression, practice, and upcoming event content. In this video, we break down the level cap change ...

Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...

Clinical outcomes from routine practice confirm ocrelizumab effectiveness in relapsing MS, with low rates of disability worsening over 4 years.

TROPION-Lung17 will enroll approximately 400 patients across global sites. Participants are randomized 1:1 to receive either Dato-DXd (6.0 mg/kg intravenously every 3 weeks) or docetaxel (75 mg/m² ...

Investigators evaluated the efficacy and safety of toripalimab versus dacarbazine as the first-line treatment in advanced melanoma predominantly of acral subtype.

Slot Faces Midfield Decision After Mac Allister Struggles at FulhamLiverpool’s draw away at Fulham has left Arne Slot with a ...

Researchers have found in a new study that adults with type 2 diabetes and cancer who used GLP-1 receptor agonists had a ...

Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...

Jimi Hendrix Experience, Cream, Mountain, Rush... Jared James Nichols argues that three is the magic number, allowing guitar ...

Zanidatamab plus chemotherapy delays progression or death in patients with untreated locally advanced or metastatic gastroesophageal adenocarcinoma.